Clinical Trial Update: An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial entry reporting a completed study of N-acetylcysteine and fenoldopam as renal protection agents during cardiac surgery. The conditions in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Failure
• Kidney Failure

Drugs mentioned

• Fenoldopam (fenoldopam)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Linda F. Barr, M.D. | Conditions: Kidney Failure, Acute, Kidney Failure, Chronic | Phase 2 | Status: COMPLETED